Seeking Alpha

adamfeuerstein

adamfeuerstein
Send Message
View as an RSS Feed
View adamfeuerstein's Comments BY TICKER:
Latest  |  Highest rated
  • Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme [View article]
    Thanks, but "baught"?

    I understand the mis-use of "their" when you mean "there," but "baught" is crazy.

    One additional bit of advice: I's generally bad form to start a sentence with "there." You could have written, "I have no doubt he is baught." Simple. Direct. "In my mind" is unnecessary.
    Jul 17 05:58 PM | 3 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme [View article]
    I'm always amazed that people like you spend hours posting messages about me. You have nothing better to do, like laundry or mowing the lawn? Excuse me, I must go drink a quart of vodka and stalk another message board. I'll be back later tonight.

    Hiccup!...
    Jul 17 05:54 PM | 2 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme [View article]
    So many conspiracy theories about my summer vacation. I'm flattered.
    Jul 17 10:43 AM | 5 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme [View article]
    The editor might delete your post because your grammar is atrocious.
    Jul 17 10:41 AM | 4 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme [View article]
    PFS is a legitimate endpoint for some cancer clinical trials, illegitimate for others. It depends on the type of cancer. For GBM, FDA has preferred overall survival. Melanoma, too, by the way.
    Jul 17 10:41 AM | 1 Like Like |Link to Comment
  • Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme [View article]
    When NWBO fails and you lose all your money, I will still accept your apology because I'm gracious and forgiving.
    Jul 17 10:38 AM | 5 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme [View article]
    You love me! I can tell, you really do.

    I had no part in Richard Pearson's article. If I did, he'd have published it at TheStreet, where I work, not on Seeking Alpha. I don't work for Seeking Alpha.

    You're not very smart.
    Jul 17 10:37 AM | 4 Likes Like |Link to Comment
  • Behind The Promotion Of Northwest Bio [View article]
    Richard doesn't work for TheStreet. He's been a contributing writer for us, but his last published article was in January.
    Jul 8 10:12 AM | Likes Like |Link to Comment
  • Behind The Promotion Of Northwest Bio [View article]
    I applaud your originality. Insane and false, but original!
    Jul 7 04:13 PM | 1 Like Like |Link to Comment
  • Behind The Promotion Of Northwest Bio [View article]
    Larry -- As I stated publicly on Twitter this morning, I believe the personal attack leveled against you in this story is unjustified.

    You're upset and we've had our differences in the past, so I understand why you've lumped me together with Richard. But let's clear up some mis-understandings. I never threatened to use the NYSE issue to silence you on NWBO.

    Here's what really went down:

    In the comments section of your last SmithonStocks blog post on NWBO, you accused me of illegal activities with respect to NWBO stock, without any proof whatsoever. I responded via private message that you shouldn't be accusing people of running afoul of securities regulations without proof given your NYSE troubles. In response, you deleted those comments. I appreciate you doing that.

    You also know that I looked into the connection between your research and MDM biotech clients months ago. We spoke about it. I also spoke to MDM's CEO. I concluded that there wasn't anything relevant to report so I never wrote about it. I strongly disagree with your analysis on most stocks, particularly NWBO. I think you got this one really wrong. However, I also believe you're not a paid shill for NWBO. I believe you when you say you weren't paid by MDM or anyone else to promote NWBO.

    Richard's discussion of your NYSE issue was off topic and out of line. It's just not relevant and should not have been used to attack your credibility.

    Adam
    Jul 7 01:57 PM | 26 Likes Like |Link to Comment
  • Inovio Pharmaceuticals Could Outperform - Dr. J. Joseph Kim, CEO, Tells Us Why [View article]
    here ya go, Trevor

    http://bit.ly/1l4K9qI
    Jun 10 12:49 PM | 2 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Management Discusses Interim Data On Phase I/II Trial Of DCVax-Direct [View article]
    NO! Wrong. Incorrect. Transplanting an artery from the leg to the heart works because an artery is simply plumbing. You're asking the "tube" to do the same thing in the heart that it did in the leg.

    Dendritic cells are already present in white blood cells and ARE NOT RECOGNIZING the tumor. Taking them out and putting them back in is not doing anything useful. The only instance where a dendritic cell vaccine has worked is Provenge, and that's because the dendritic cells were primed ex-vivo to recognize the one antigen in prostate cancer that appears to play a major role in the disease. Dendreon got lucky. Provenge would not work if it was simply expanded dendritic cells re-injected back into the body.

    It is absurd to believe the dendritic cells in DCVAX-Direct are going to magically attach themselves to antigen simply because you inject the tumor.
    May 29 04:18 PM | 3 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Management Discusses Interim Data On Phase I/II Trial Of DCVax-Direct [View article]
    Larry, my friend... let me try to explain this to you in the simplest of terms. Dendritic cells are already in the body and aren't capable of recognizing the tumor antigens. That is why these people have cancer! (Well, one reason, not the only, but let's not digress.)

    With DCVax-Direct, the only thing NWBO is doing is removing the ineffectual dendritic cells from white blood cells and then re-injecting them back into the same patient. That's it! This is the idiot's approach to immunotherapy, which is why NWBO is trying it, and you believe it.

    At least with DC-Vax, NWBO is bathing the dendritic cells with the tumor antigens ex-vivo and then re-injecting. This approach won't work either, but at least it makes a teeny tiny bit of sense.
    May 29 03:05 PM | 2 Likes Like |Link to Comment
  • Northwest Biotherapeutics: Management Discusses Interim Data On Phase I/II Trial Of DCVax-Direct [View article]
    Six months since that DC-Vax GBM efficacy interim analysis was started, results still MIA...

    Where are the data, Linda?
    May 28 09:27 PM | 1 Like Like |Link to Comment
  • Northwest Biotherapeutics: Management Discusses Interim Data On Phase I/II Trial Of DCVax-Direct [View article]
    Most absurd, but entirely lost on mindless simpletons who own NWBO, is the fact that DC-VAX Direct consists of dendritic cells removed from a patient's blood, which are then re-injected into a tumor, where they are supposed to magically pick up tumor antigens and kick off an immune system storm to kill the same tumor.

    This is the stuff of loony-bin fantasies.
    May 28 09:26 PM | 1 Like Like |Link to Comment
COMMENTS STATS
303 Comments
450 Likes